CN111004831B - 一种粪便保存液及其制备方法和应用 - Google Patents
一种粪便保存液及其制备方法和应用 Download PDFInfo
- Publication number
- CN111004831B CN111004831B CN201911413756.8A CN201911413756A CN111004831B CN 111004831 B CN111004831 B CN 111004831B CN 201911413756 A CN201911413756 A CN 201911413756A CN 111004831 B CN111004831 B CN 111004831B
- Authority
- CN
- China
- Prior art keywords
- excrement
- preservation solution
- feces
- preservation
- stool
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 238000003860 storage Methods 0.000 title claims abstract description 28
- 239000007788 liquid Substances 0.000 title claims abstract description 20
- 238000002360 preparation method Methods 0.000 title abstract description 12
- 210000003608 fece Anatomy 0.000 claims abstract description 34
- 239000003761 preservation solution Substances 0.000 claims abstract description 34
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims abstract description 24
- OSASVXMJTNOKOY-UHFFFAOYSA-N chlorobutanol Chemical compound CC(C)(O)C(Cl)(Cl)Cl OSASVXMJTNOKOY-UHFFFAOYSA-N 0.000 claims abstract description 24
- 239000002202 Polyethylene glycol Substances 0.000 claims abstract description 22
- 229920001223 polyethylene glycol Polymers 0.000 claims abstract description 22
- 238000004321 preservation Methods 0.000 claims abstract description 20
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 claims abstract description 12
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 claims abstract description 12
- 229960004926 chlorobutanol Drugs 0.000 claims abstract description 12
- 229960001484 edetic acid Drugs 0.000 claims abstract description 12
- 239000011780 sodium chloride Substances 0.000 claims abstract description 12
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 claims abstract description 12
- 102000039446 nucleic acids Human genes 0.000 claims abstract description 10
- 108020004707 nucleic acids Proteins 0.000 claims abstract description 10
- 150000007523 nucleic acids Chemical class 0.000 claims abstract description 10
- 238000000034 method Methods 0.000 claims description 12
- 229920000604 Polyethylene Glycol 200 Polymers 0.000 claims description 9
- 238000002156 mixing Methods 0.000 claims description 7
- 239000008367 deionised water Substances 0.000 claims description 4
- 229910021641 deionized water Inorganic materials 0.000 claims description 4
- 238000001914 filtration Methods 0.000 claims description 4
- 239000012528 membrane Substances 0.000 claims description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 4
- 229960002668 sodium chloride Drugs 0.000 claims 1
- 229940083575 sodium dodecyl sulfate Drugs 0.000 claims 1
- 239000000203 mixture Substances 0.000 abstract description 14
- 244000005700 microbiome Species 0.000 abstract description 12
- 238000010923 batch production Methods 0.000 abstract description 4
- 230000007613 environmental effect Effects 0.000 abstract description 4
- 230000001580 bacterial effect Effects 0.000 abstract description 2
- 238000001514 detection method Methods 0.000 description 12
- 239000000243 solution Substances 0.000 description 9
- 230000009286 beneficial effect Effects 0.000 description 8
- 102000007469 Actins Human genes 0.000 description 7
- 108010085238 Actins Proteins 0.000 description 7
- 241000588724 Escherichia coli Species 0.000 description 7
- 241000894006 Bacteria Species 0.000 description 6
- 230000000052 comparative effect Effects 0.000 description 6
- 230000002550 fecal effect Effects 0.000 description 6
- 230000000694 effects Effects 0.000 description 5
- 238000007400 DNA extraction Methods 0.000 description 4
- 239000002699 waste material Substances 0.000 description 4
- 238000007710 freezing Methods 0.000 description 3
- 230000008014 freezing Effects 0.000 description 3
- 210000001035 gastrointestinal tract Anatomy 0.000 description 3
- 150000002632 lipids Chemical class 0.000 description 3
- 238000007789 sealing Methods 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 238000005303 weighing Methods 0.000 description 3
- 206010009944 Colon cancer Diseases 0.000 description 2
- 208000001333 Colorectal Neoplasms Diseases 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 2
- 229920002565 Polyethylene Glycol 400 Polymers 0.000 description 2
- 229920002582 Polyethylene Glycol 600 Polymers 0.000 description 2
- 239000000872 buffer Substances 0.000 description 2
- 239000003112 inhibitor Substances 0.000 description 2
- 230000000968 intestinal effect Effects 0.000 description 2
- 210000002429 large intestine Anatomy 0.000 description 2
- JLFNLZLINWHATN-UHFFFAOYSA-N pentaethylene glycol Chemical compound OCCOCCOCCOCCOCCO JLFNLZLINWHATN-UHFFFAOYSA-N 0.000 description 2
- 229920002523 polyethylene Glycol 1000 Polymers 0.000 description 2
- 108010067770 Endopeptidase K Proteins 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 238000005842 biochemical reaction Methods 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 230000013872 defecation Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 230000000593 degrading effect Effects 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- YQOKLYTXVFAUCW-UHFFFAOYSA-N guanidine;isothiocyanic acid Chemical compound N=C=S.NC(N)=N YQOKLYTXVFAUCW-UHFFFAOYSA-N 0.000 description 1
- 238000000703 high-speed centrifugation Methods 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 230000010355 oscillation Effects 0.000 description 1
- 230000036961 partial effect Effects 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 238000010257 thawing Methods 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
- C12Q1/24—Methods of sampling, or inoculating or spreading a sample; Methods of physically isolating an intact microorganisms
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Analytical Chemistry (AREA)
- Pathology (AREA)
- Immunology (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
Description
原料名称 | 对比例1 | 实施例1 | 实施例2 | 实施例3 |
三羟甲基氨基甲烷 | 0.20M | 0.20M | 0.15M | 0.30M |
乙二胺四乙酸 | 0.30M | 0.30M | 0.25M | 0.55M |
氯化钠 | 7mM | 5mM | 10mM | 20mM |
十二烷基硫酸钠 | / | 2%(w/v) | 1(w/v) | 3(w/v) |
氯丁醇 | / | 25%(v/v) | 10(v/v) | 35(v/v) |
聚乙二醇PEG200 | / | 15%(v/v) | 10(v/v) | 30(v/v) |
异硫氰酸胍 | 0.5M | / | / | / |
无水乙醇 | 20% | / | / | / |
样本 | 浓度(ng/μl) |
S1-1 | 152.61 |
S1-2 | 112.62 |
S1-3 | 215.31 |
S1-4 | 88.26 |
S2-1 | 149.38 |
S2-2 | 130.85 |
S2-3 | 224.37 |
S2-4 | 85.41 |
S3-1 | 209.46 |
S3-2 | 155.48 |
S3-3 | 274.58 |
S3-4 | 96.35 |
样本 | 浓度(ng/μl) |
S5-200 | 237.12 |
S5-400 | 178.87 |
S5-600 | 123.52 |
S5-1000 | 97.09 |
S6-200 | 187.94 |
S6-400 | 115.32 |
S6-600 | 91.53 |
S6-1000 | 72.21 |
S7-200 | 210.77 |
S7-400 | 175.84 |
S7-600 | 124.56 |
S7-1000 | 99.66 |
Claims (5)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201911413756.8A CN111004831B (zh) | 2019-12-31 | 2019-12-31 | 一种粪便保存液及其制备方法和应用 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201911413756.8A CN111004831B (zh) | 2019-12-31 | 2019-12-31 | 一种粪便保存液及其制备方法和应用 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN111004831A CN111004831A (zh) | 2020-04-14 |
CN111004831B true CN111004831B (zh) | 2022-10-21 |
Family
ID=70119957
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201911413756.8A Active CN111004831B (zh) | 2019-12-31 | 2019-12-31 | 一种粪便保存液及其制备方法和应用 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN111004831B (zh) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113729008A (zh) * | 2021-09-30 | 2021-12-03 | 苏州中科先进技术研究院有限公司 | 一种粪便保存液、制备方法及其应用 |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105716917A (zh) * | 2016-01-22 | 2016-06-29 | 杭州奥泰生物技术有限公司 | 一种用于保护并稳定粪便中血红蛋白的收集液及其应用 |
CN107980763A (zh) * | 2017-11-10 | 2018-05-04 | 人和未来生物科技(长沙)有限公司 | 一种粪便保存试剂及其应用 |
CN109122667A (zh) * | 2018-09-27 | 2019-01-04 | 广州新诚生物科技有限公司 | 保存液及其制备方法和应用 |
CN109609600A (zh) * | 2019-01-31 | 2019-04-12 | 浙江大学 | 常温下一种粪便样本的dna保存液及其制备方法和用途 |
CN110004212A (zh) * | 2019-04-23 | 2019-07-12 | 康美华大基因技术有限公司 | 粪便保存液及其制备方法和保存粪便的方法 |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPWO2010024251A1 (ja) * | 2008-08-26 | 2012-01-26 | オリンパス株式会社 | 糞便試料の調製方法、糞便試料調製用溶液、及び採便用キット |
-
2019
- 2019-12-31 CN CN201911413756.8A patent/CN111004831B/zh active Active
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105716917A (zh) * | 2016-01-22 | 2016-06-29 | 杭州奥泰生物技术有限公司 | 一种用于保护并稳定粪便中血红蛋白的收集液及其应用 |
CN107980763A (zh) * | 2017-11-10 | 2018-05-04 | 人和未来生物科技(长沙)有限公司 | 一种粪便保存试剂及其应用 |
CN109122667A (zh) * | 2018-09-27 | 2019-01-04 | 广州新诚生物科技有限公司 | 保存液及其制备方法和应用 |
CN109609600A (zh) * | 2019-01-31 | 2019-04-12 | 浙江大学 | 常温下一种粪便样本的dna保存液及其制备方法和用途 |
CN110004212A (zh) * | 2019-04-23 | 2019-07-12 | 康美华大基因技术有限公司 | 粪便保存液及其制备方法和保存粪便的方法 |
Non-Patent Citations (1)
Title |
---|
粪菌低温保存的研究进展;火晓越,等;《制冷学报》;20191021;第40卷(第6期);142-150 * |
Also Published As
Publication number | Publication date |
---|---|
CN111004831A (zh) | 2020-04-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US10731146B2 (en) | Purification of nucleic acid from environmental or biological samples | |
Cazaudehore et al. | Methane production and active microbial communities during anaerobic digestion of three commercial biodegradable coffee capsules under mesophilic and thermophilic conditions | |
Eikmeyer et al. | Metagenome analyses reveal the influence of the inoculant Lactobacillus buchneri CD034 on the microbial community involved in grass ensiling | |
Wang et al. | Variations in bacterial taxonomic profiles and potential functions in response to the gut transit of earthworms (Eisenia fetida) feeding on cow manure | |
Kim et al. | Response of a continuous anaerobic digester to temperature transitions: A critical range for restructuring the microbial community structure and function | |
Zeng et al. | The impact and fate of clarithromycin in anaerobic digestion of waste activated sludge for biogas production | |
Gorrens et al. | Isolation and identification of dominant bacteria from black soldier fly larvae (Hermetia illucens) envisaging practical applications | |
Sierocinski et al. | Biodiversity–function relationships in methanogenic communities | |
CN111826371A (zh) | 粪便核酸保存液及其制备方法和应用 | |
CN109371008B (zh) | 一种核酸提取扩增检测试剂盒 | |
CN111004831B (zh) | 一种粪便保存液及其制备方法和应用 | |
CN108192827A (zh) | 一种肠道菌群样本常温保存液及其制备方法和用途 | |
CN114369537A (zh) | 粪便保存液及其制备方法和应用 | |
Wang et al. | Response to inhibitory conditions of acetate-degrading methanogenic microbial community | |
CN105543095A (zh) | 一种富含有机质的微生物样品的保存试剂、包含该保存试剂的试剂盒及其应用 | |
CN102220309A (zh) | 一种厌氧反应器中活性污泥dna的提取方法 | |
Zavala-Alvarado et al. | The single-step method of RNA purification applied to Leptospira | |
EP2984101A1 (en) | Kits and methods for isolating protein from biological and environmental samples | |
CN107034141A (zh) | 人粪便中肠道菌群固定液及其制备方法 | |
CN105039306A (zh) | 一种唾液保护剂 | |
CN112226369A (zh) | 一种肠道菌群保存液及制备方法 | |
CN111139236A (zh) | 一种粪便样品稳定液及其制备、使用方法 | |
Li et al. | An improved RNA isolation method for filamentous fungus Blakeslea trispora rich in polysaccharides | |
CN115786448A (zh) | 一种肠道微生物常温保存液及其制备方法和应用 | |
Gunwantrao et al. | Bacterial succession during Panchagavya making as revealed by DGGE analysis |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
CP03 | Change of name, title or address |
Address after: 350108 floor 1, block a, jiuce building, Haixi hi tech Industrial Park, Fuzhou hi tech Zone, Fujian Province Patentee after: Fujian Aji'an Biotechnology Co.,Ltd. Country or region after: China Address before: 350108 floor 1, block a, jiuce building, Haixi hi tech Industrial Park, Fuzhou hi tech Zone, Fujian Province Patentee before: RGI (FUZHOU) GENETIC MEDICINE LABORATORY Co.,Ltd. Country or region before: China |
|
CP03 | Change of name, title or address | ||
CP03 | Change of name, title or address |
Address after: Floor 7, Building 16, Phase II, Innovation Park, No.7 Wulongjiang Middle Avenue, High tech Zone, Fuzhou City, Fujian Province, 350108 Patentee after: Fujian Aji'an Biotechnology Co.,Ltd. Country or region after: China Address before: 350108 floor 1, block a, jiuce building, Haixi hi tech Industrial Park, Fuzhou hi tech Zone, Fujian Province Patentee before: Fujian Aji'an Biotechnology Co.,Ltd. Country or region before: China |
|
CP03 | Change of name, title or address |